miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

Rinnerthaler, G; Hackl, H; Gampenrieder, SP; Hamacher, F; Hufnagl, C; Hauser-Kronberger, C; Zehentmayr, F; Fastner, G; Sedlmayer, F; Mlineritsch, B; Greil, R; Int J Mol Sci. 2016; 17(2):

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

Benedetti, D; Tissino, E; Caldana, C; Dal Bo, M; Bomben, R; Marconi, D; Ganghammer, S; Zaja, F; Pozzato, G; Di Raimondo, F; Hartmann, TN; Del Poeta, G; VanMeter, A; Zucchetto, A; Espina, V; Liotta, L; Gattei, V; Leukemia. 2016; 30(2): 513-517.

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

Pikija, S; Pilz, G; Gschwandtner, G; Rösler, C; Schlick, K; Greil, R; Sellner, J; Front Neurol. 2016; 7:196

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

Haerzschel, A; Catusse, J; Hutterer, E; Paunovic, M; Zirlik, K; Eibel, H; Krenn, PW; Hartmann, TN; Burger, M; Ann Hematol. 2016; 95(12): 1979-1988.

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A; Oncotarget. 2016; 7(32):51494-51502

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.

Zaborsky, N; Gassner, FJ; Asslaber, D; Reinthaler, P; Denk, U; Flenady, S; Hofbauer, JP; Danner, B; Rebhandl, S; Harrer, A; Geisberger, R; Greil, R; Egle, A; Oncotarget. 2016; 7(31):4945-49469

DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.

Boige, V; Vincent, M; Alexandre, P; Tejpar, S; Landolfi, S; Le Malicot, K; Greil, R; Cuyle, PJ; Yilmaz, M; Faroux, R; Matzdorff, A; Salazar, R; Lepage, C; Taieb, J; Laurent-Puig, P; JAMA Oncol. 2016; 2(5):655-662

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).

Willenbacher, W; Thangavadivel, S; Greil, R; Willenbacher, E; Weger, R; Manzl, C; Jöhrer, K; Brunner, A; Leuk Lymphoma. 2016; 57(10):2330-2341

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

Rachar, V; Czejka, M; Kitzmueller, M; Buchner, P; Lichtneckert, M; Greil, R; Geiler, H; Dittrich, C; Anticancer Res. 2016; 36(9):4715-4723

CD44: More than a mere stem cell marker.

Morath, I; Hartmann, TN; Orian-Rousseau, V; Int J Biochem Cell Biol. 2016; 81(Pt A):166-173